N0-1-CM-47681-01/CM/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
1990	1
1992	2
2025	0

Page 1

Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.

Ernstoff MS, Gooding W, Nair S, Bahnson RR, Miketic LM, Banner B, Day R, Whiteside T, Titus-Ernstoff L, Kirkwood JM. Ernstoff MS, et al. Cancer Res. 1992 Feb 15;52(4):851-6. Cancer Res. 1992. PMID: 1737346 Clinical Trial.

A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.

Ernstoff MS, Nair S, Bahnson RR, Miketic LM, Banner B, Gooding W, Day R, Whiteside T, Hakala T, Kirkwood JM. Ernstoff MS, et al. J Clin Oncol. 1990 Oct;8(10):1637-49. doi: 10.1200/JCO.1990.8.10.1637. J Clin Oncol. 1990. PMID: 2120392

Interferon-induced reversible acute renal failure with nephrotic syndrome.

Nair S, Ernstoff MS, Bahnson RR, Arthur S, Johnston J, Downs MA, Neuhart J, Kirkwood JM. Nair S, et al. Urology. 1992 Feb;39(2):169-72. doi: 10.1016/0090-4295(92)90277-4. Urology. 1992. PMID: 1736513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year